Skip to main content
. 2022 Mar 21;8(3):e09145. doi: 10.1016/j.heliyon.2022.e09145

Figure 13.

Figure 13

Bacterial growth for the 1.1% and 1.5% (w/v) gelatin with 0.7% (w/v) PVA and 20 μg/mL GO-Ag NPs treatment, the commercial treatments, and the positive control (n = 15). ∗, p < 0.05.